- Lobbying
- Lobbying by GeoVax Labs, Inc
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
John Mashburn | Sen. Judd Gregg, GC; Maj. L. Trent Lott, GC; Rep. Conf. Sec. Paul Coverdell, GC; Maj. W. Tom Delay, Policy Director |
Lori Salley | Rep. Deborah Pryce, COS; House Rep. Conf., Dep. COS; House Small Bus. Comm, Research Asst.; Rules Comm, Associate |
Mark Harkins | Rep. Brad Miller, COS; House Comm on Science, Leg. Dir. |
Peggy Binzer | Health Counsel, Senate Budget Committee |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Budget
Health Issues
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Budget
Health Issues
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Budget
Health Issues
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Budget
Health Issues
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: To raise Congressional awareness regarding the need for an HIV/AIDS vaccine; Ryan White Act reauthorization issues.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate